{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:49:33Z","timestamp":1792597773650,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015438","name":"International Society on Thrombosis and Haemostasis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1111\/jth.15808","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T06:33:53Z","timestamp":1657262033000},"page":"2214-2225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["ISTH guidelines for antithrombotic treatment in COVID\u201019"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8512-9043","authenticated-orcid":false,"given":"Sam","family":"Schulman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1220-0301","authenticated-orcid":false,"given":"Michelle","family":"Sholzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-461X","authenticated-orcid":false,"given":"Alex C.","family":"Spyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9455-6138","authenticated-orcid":false,"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8246-2668","authenticated-orcid":false,"given":"Helaine E.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-8165","authenticated-orcid":false,"given":"Charlotte A.","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-582X","authenticated-orcid":false,"given":"Jean Marie","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5007-3457","authenticated-orcid":false,"given":"Anna","family":"Falanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3080-3328","authenticated-orcid":false,"given":"Scott","family":"Kaatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-6420","authenticated-orcid":false,"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-4689","authenticated-orcid":false,"given":"Tracy","family":"Minichiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5735-1333","authenticated-orcid":false,"given":"Eduardo","family":"Ramacciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0460-6491","authenticated-orcid":false,"given":"Charles Marc","family":"Samama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-0993","authenticated-orcid":false,"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-2322","authenticated-orcid":false,"given":"Lisa","family":"Broxmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"International Society on Thrombosis and Haemostasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15808_bb0010","first-page":"157","article-title":"WHO declares COVID\u201019 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1111\/jth.15808_bb0015","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Clinical guidance on the diagnosis, prevention and treatment of venous thromboembolism in hospitalized patients with COVID\u201019","volume":"18","author":"Spyropoulos","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID\u201019","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0025","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1111\/jth.15809","article-title":"Good practice statements for antithrombotic therapy in the management of COVID\u201019","volume":"20","author":"Spyropoulos","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIR.0b013e31827e8e5f","article-title":"ACCF\/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"127","author":"Jacobs","year":"2013","journal-title":"Circulation"},{"key":"10.1111\/jth.15808_bb0035","unstructured":"ACCF\/AHA. Methodology Manual and Policies From the ACCF\/AHA Task Force on Practice Guidelines. https:\/\/www.acc.org\/\u2010\/media\/Non\u2010Clinical\/Files\u2010PDFs\u2010Excel\u2010MS\u2010Word\u2010etc\/Guidelines\/About\u2010Guidelines\u2010and\u2010Clinical\u2010Documents\/Methodology\/2014\/Methodology\u2010Practice\u2010Guidelines.pdf?la=en&hash=CBE36C37EF806E7C7B193DD4450C5D190DEBB5E3 [accessed 2022, March 17]."},{"key":"10.1111\/jth.15808_bb0040","unstructured":"Abstrackr. Brown University, School of Public Health. https:\/\/www.brown.edu\/public\u2010health\/cesh\/resources\/software#:~:text=using%20these%20tools.\u2010,Abstrackr,your%20abstracts%20in%20one%20place [accessed 2022, March 17]."},{"key":"10.1111\/jth.15808_bb0045","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 63 (Updated February 2022): Cochrane","article-title":"Chapter 8: assessing risk of bias in a randomized trial","author":"Higgins","year":"2022"},{"key":"10.1111\/jth.15808_bb0050","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID\u201019: the ACTIV\u20104B randomized clinical trial","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA"},{"key":"10.1111\/jth.15808_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/joim.13205","article-title":"Direct oral anticoagulant use and risk of severe COVID\u201019","volume":"289","author":"Flam","year":"2021","journal-title":"J Intern Med"},{"key":"10.1111\/jth.15808_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2021.06.014","article-title":"Direct\u2010acting oral anticoagulants use prior to COVID\u201019 diagnosis and associations with 30\u2010day clinical outcomes","volume":"205","author":"Rivera\u2010Caravaca","year":"2021","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15808_bb0065","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1055\/a-1414-5216","article-title":"Sulodexide in the treatment of patients with early stages of COVID\u201019: a randomized controlled trial","volume":"121","author":"Gonzalez\u2010Ochoa","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0070","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID\u201019","volume":"76","author":"Piazza","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15808_bb0075","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non\u2010major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non\u2010surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246825","article-title":"Association of mortality and aspirin prescription for COVID\u201019 patients at the veterans health administration","volume":"16","author":"Osborne","year":"2021","journal-title":"PLoS One"},{"key":"10.1111\/jth.15808_bb0085","article-title":"Chronic anticoagulant treatment and risk of mortality in SARS\u2010Cov2 patients: a large population\u2010based study","author":"Montorfano","year":"2022","journal-title":"Minerva Med"},{"key":"10.1111\/jth.15808_bb0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2021.12.010","article-title":"The association between anticoagulation and adverse outcomes after a positive SARS\u2010CoV\u20102 test among older outpatients: a population\u2010based cohort study","volume":"211","author":"Abdel\u2010Qadir","year":"2022","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15808_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101139","article-title":"Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID\u201019 patients","volume":"41","author":"Hozayen","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1111\/jth.15808_bb0100","unstructured":"Gobierno de Mexico\u2010 IMSS. Calculadora de complicacion de salud por COVID\u201019. http:\/\/www.imss.gob.mx\/covid\u201019\/calculadora\u2010complicaciones [accessed 2022, June 10]."},{"key":"10.1111\/jth.15808_bb0105","first-page":"264","article-title":"Pre\u2010 and in\u2010hospital anticoagulation therapy in coronavirus disease 2019 patients: a propensity\u2010matched analysis of in\u2010hospital outcomes","volume":"22","author":"Battistoni","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1111\/jth.15808_bb0110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1055\/a-1366-9656","article-title":"Prevalence and predictors of venous thromboembolism or mortality in hospitalized COVID\u201019 patients","volume":"121","author":"Cohen","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1055\/a-1347-6070","article-title":"Heparin in COVID\u201019 patients is associated with reduced in\u2010hospital mortality: the multicenter Italian CORIST study","volume":"121","author":"Di Castelnuovo","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/ejh.13533","article-title":"Association of anticoagulation dose and survival in hospitalized COVID\u201019 patients: a retrospective propensity score\u2010weighted analysis","volume":"106","author":"Ionescu","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.15808_bb0125","article-title":"Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study","volume":"372","author":"Rentsch","year":"2021","journal-title":"BMJ"},{"key":"10.1111\/jth.15808_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10557-020-07133-3","article-title":"The association of low molecular weight heparin use and in\u2010hospital mortality among patients hospitalized with COVID\u201019","volume":"36","author":"Shen","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1111\/jth.15808_bb0135","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s11739-021-02891-w","article-title":"Low in\u2010hospital mortality rate in patients with COVID\u201019 receiving thromboprophylaxis: data from the multicentre observational START\u2010COVID register","volume":"17","author":"Poli","year":"2022","journal-title":"Intern Emerg Med"},{"key":"10.1111\/jth.15808_bb0140","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid\u201019 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ"},{"key":"10.1111\/jth.15808_bb0145","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic\u2010dose heparin vs standard prophylactic or intermediate\u2010dose heparins for thromboprophylaxis in high\u2010risk hospitalized patients with COVID\u201019: the HEP\u2010COVID randomized clinical trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1111\/jth.15808_bb0150","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid\u201019","volume":"385","author":"Lawler","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15808_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12638","article-title":"Randomized trials of therapeutic heparin for COVID\u201019: a meta\u2010analysis","volume":"5","author":"Sholzberg","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/1516-3180.2021.0098.r1.08062021","article-title":"Low molecular weight heparin is useful in adult COVID\u201019 inpatients. Experience during the first Spanish wave: observational study","volume":"140","author":"Gonzalez\u2010Porras","year":"2022","journal-title":"Sao Paulo Med J"},{"key":"10.1111\/jth.15808_bb0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajh.26102","article-title":"Intermediate\u2010dose anticoagulation, aspirin, and in\u2010hospital mortality in COVID\u201019: a propensity score\u2010matched analysis","volume":"96","author":"Meizlish","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.15808_bb0170","article-title":"Enoxaparin for thromboprophylaxis in hospitalized COVID\u201019 patients: the X\u2010COVID\u201019 randomized trial","volume":"52","author":"Morici","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/jth.15808_bb0175","article-title":"Intermediate\u2010 vs. standard\u2010dose prophylactic anticoagulation in patients with COVID\u201019 admitted in medical Ward: a propensity score\u2010matched cohort study","volume":"8","author":"Smadja","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1111\/jth.15808_bb0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non\u2010critically ill hospitalized patients with COVID\u201019: a randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"Jama"},{"key":"10.1111\/jth.15808_bb0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01825-0","article-title":"Aspirin in patients admitted to hospital with COVID\u201019 (RECOVERY): a randomised, controlled, open\u2010label, platform trial","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1111\/jth.15808_bb0190","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID\u201019 and elevated D\u2010dimer concentration (ACTION): an open\u2010label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"key":"10.1111\/jth.15808_bb0195","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1093\/cvr\/cvab308","article-title":"Low\u2010molecular\u2010weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study","volume":"117","author":"Pereyra","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1111\/jth.15808_bb0200","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID\u201019: a systematic review and meta\u2010analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1111\/jth.15808_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15808_bb0210","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo\u2010controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/jth.15808_bb0215","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0220","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1538-7836.2006.01818.x","article-title":"Identifying acutely ill medical patients requiring thromboprophylaxis","volume":"4","author":"Chopard","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0225","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1055\/s-0037-1603929","article-title":"The IMPROVEDD VTE risk score: incorporation of D\u2010dimer into the IMPROVE score to improve venous thromboembolism risk stratification","volume":"1","author":"Gibson","year":"2017","journal-title":"TH Open"},{"key":"10.1111\/jth.15808_bb0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/a-1485-2372","article-title":"Intermediate\u2010dose versus standard\u2010dose prophylactic anticoagulation in patients with COVID\u201019 admitted to the iIntensive care unit: 90\u2010day results from the INSPIRATION randomized trial","volume":"122","author":"Bikdeli","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0235","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jth.15450","article-title":"Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID\u201019: a multi\u2010center, open\u2010label, randomized controlled trial","volume":"19","author":"Perepu","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0240","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"},{"key":"10.1111\/jth.15808_bb0245","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid\u201019","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15808_bb0250","first-page":"1032","article-title":"Comparison of the effect of unfractionated heparin and enoxaparin sodium at different doses on the course of COVID\u201019\u2010associated coagulopathy","volume":"11","author":"Oliynyk","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1111\/jth.15808_bb0255","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.2022.2910","article-title":"Effect of antiplatelet therapy on survival and organ support\u2010free days in critically ill patients with COVID\u201019: a randomized clinical trial","volume":"327","author":"Bradbury","year":"2022","journal-title":"Jama"},{"key":"10.1111\/jth.15808_bb0260","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","article-title":"Dalteparin versus unfractionated heparin in critically ill patients","volume":"364","author":"Cook","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15808_bb0265","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15808_bb0270","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID\u201019: a randomized phase II clinical trial (HESACOVID)","volume":"196","author":"Lemos","year":"2020","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15808_bb0275","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non\u2010surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15808_bb0280","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood.2020010529","article-title":"Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID\u201019: the CORE\u201019 registry","volume":"137","author":"Giannis","year":"2021","journal-title":"Blood"},{"key":"10.1111\/jth.15808_bb0285","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post\u2010discharge thromboprophylaxis after hospitalisation for COVID\u201019 (MICHELLE): an open\u2010label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti","year":"2022","journal-title":"Lancet"},{"key":"10.1111\/jth.15808_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109232","article-title":"A prospective study of the impact of glycaemic status on clinical outcomes and anti\u2010SARS\u2010CoV\u20102 antibody responses among patients with predominantly non\u2010severe COVID\u201019","volume":"185","author":"Lui","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/jth.15808_bb0295","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.jacc.2020.04.071","article-title":"Post\u2010discharge prophylaxis with rivaroxaban reduces fatal and major thromboembolic events in medically ill patients","volume":"75","author":"Spyropoulos","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15808_bb0300","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13045-021-01185-0","article-title":"Association between warfarin and COVID\u201019\u2010related outcomes compared with direct oral anticoagulants: population\u2010based cohort study","volume":"14","author":"Wong","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1111\/jth.15808_bb0305","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15808","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622190422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622190422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:35:21Z","timestamp":1761536121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622190422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1538783622190422"],"URL":"https:\/\/doi.org\/10.1111\/jth.15808","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ISTH guidelines for antithrombotic treatment in COVID\u201019","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}